Project Details
| Status | Active |
|---|---|
| Effective start/end date | 12/13/24 → 12/13/27 |
Funding
- Vertex Pharmaceuticals Incorporated (Prot #VX21-147-301)
Prot #VX21-147-301: A Phase 2/3 Adaptive, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of VX-147 in Adult and Pediatric Subjects With APOL1-Mediated Proteinuric Kidney Disease
- Ghossein, Cybele (PD/PI)
Project: Research project